Clinical Trial Update: Safety and Efficacy Study in Subjects With Chronic HCV and Underlying Hemophilia [Phase 3]

View source ↗

Summary

Phase 3 safety and efficacy study in subjects with chronic hepatitis C virus infection and underlying hemophilia has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis C Virus | Phase 3 | Status: COMPLETED | Results posted: 2019-06-24